Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics have?
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics has 101 citations in the OpenAlex counts ScholarIQ stores.
When was Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics published?
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics has 2022 year in the ScholarIQ index.
What is the open-access status of Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics?
Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics has green oa status in the ScholarIQ index.
What is the DOI of Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics?
The DOI for Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics is on the source record.
What is the PMID of Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics?
The PMID for Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics is on the source record.
What is the OpenAlex record for Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics?
The OpenAlex for Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics is on the source record.